Virtual Journal Club
This activity is free to ASM members.
March 3 Update: Due to COVID-19 the March Session has been moved to April.
New Antibiotics: Cefiderocol and Lefamulin
April 14 Session
Articles for Discussion
Michael Jacobs et al., ARGONAUT-I: Activity of Cefiderocol (S-649266), a Siderophore Cephalosporin, against Gram-Negative Bacteria, Including Carbapenem-Resistant Nonfermenters and Enterobacteriaceae with Defined Extended-Spectrum B-Lactamases and Carbapenemases, Antimicrobial Agents and Chemotherapy, Volume 63, Issue 1, Jan 2019. DOI: 10.1128/AAC.01801-18.
Susanne Paukner et al., Antibacterial Activity of Lefamulin against Pathogens Most Commonly Causing Community-Acquired Bacterial Pneumonia: SENTRY Antimicrobial Surveillance Program, Antimicrobial Agents and Chemotherapy, Volume 63, Issue 4, Apr 2019. DOI: 10.1128/AAC.02161-18.
Stay tuned for upcoming topics and registration!
Arryn Craney PhD, D(ABMM), Weill Cornell Medicine
Nicholas Moore PhD, MLS(ASCP)cm, Rush University
Matthew Pettengill, PhD, D(ABMM), Thomas Jefferson University
Joseph Blondeau, PhD, FCCP, Royal University Hospital, Saskatchewan
Jessica Bohrhunter, PhD, CPEP, CPEP Fellow of the University of Rochester
James Kirby, MD, D(ABMM), Beth Israel Deaconess, Harvard Medical School
Next Session Date
May 12, 2020
ArchivesMissed a past virtual journal club? Catch up by watching recordings on ASM Events Online.
Questions? Email Nicole Jackson at firstname.lastname@example.org.